MENU Quick Go
Navigation
Contents
We are attending to JP Morgan Healthcare Conferenc...
PharmAbcine will give a presentation at the BIOTEC...
October 30 - November 2, PharmAbcine is presenting...
December 4-8, PharmAbcine is presenting recent R&D...
PharmAbcine published recent R&D progress in Arch....
PharmAbcine published recent dual target antibody ...
PharmAbcine closes USD $6 million Series A financi...
Korean Bio Venture firm PharmAbcine wins GATE awar...